Innovative Research Award
Francesco Ferrara – ASL Napoli 3 SUD, Italy
Francesco Ferrara is an Italian hospital pharmacist and researcher affiliated with ASL Napoli 3 SUD. His academic profile demonstrates extensive contributions to pharmacology, clinical pharmacy, healthcare governance, and therapeutic innovation. Through a substantial publication record and active international collaboration, he has contributed to evidence-based healthcare practices and multidisciplinary medical research.[1]
Abstract
This article evaluates the scholarly profile of Francesco Ferrara in relation to the Innovative Research Award. His research activities encompass pharmacology, healthcare management, antimicrobial resistance, chronic disease treatment, and pharmaceutical policy. The combination of publication productivity, citation influence, and interdisciplinary engagement highlights a sustained commitment to advancing healthcare knowledge and clinical practice.[1]
Keywords
Pharmacology, Clinical Pharmacy, Healthcare Governance, Drug Policy, Therapeutic Innovation, Antimicrobial Resistance, Pharmaceutical Research.
Introduction
Modern healthcare requires researchers capable of integrating clinical evidence, pharmaceutical management, and public health priorities. Francesco Ferrara has developed a multidisciplinary portfolio addressing therapeutic effectiveness, healthcare sustainability, and emerging treatment strategies. His work reflects contemporary priorities in patient-centered care and pharmaceutical innovation.[2]
Research Profile
Ferrara serves within the Italian Health Service and has accumulated professional experience across multiple healthcare institutions. His expertise includes clinical pharmacy, pharmacoeconomics, healthcare technology assessment, and pharmaceutical governance. The researcher maintains active participation in scientific publishing and peer-review activities across internationally recognized journals.[1]
Research Contributions
Key contributions include investigations into antimicrobial resistance, biosimilar medicines, chronic disease management, neurological disorders, dermatological therapies, and healthcare expenditure analysis. His research frequently combines clinical relevance with policy implications, supporting informed decision-making in healthcare systems and pharmaceutical practice.[3]
Publications
Publications
Francesco Ferrara has authored and co-authored an extensive portfolio of scholarly publications spanning pharmacology, clinical pharmacy, antimicrobial resistance, chronic disease management, dermatology, neurology, cardiovascular medicine, and healthcare governance. His research has appeared in internationally recognized journals including Inflammopharmacology, European Journal of Clinical Pharmacology, Pharmaceuticals, Antibodies, and Hospital Pharmacy. Through collaborations with multidisciplinary research teams, he has contributed to studies addressing therapeutic innovation, drug utilization, public health challenges, and evidence-based healthcare policies. The breadth and consistency of his publication record demonstrate sustained scientific productivity and a commitment to advancing pharmaceutical and clinical research across diverse healthcare settings.[2][3]
Research Impact
With more than two thousand citations and a substantial h-index, Ferrara’s scholarly output demonstrates measurable academic influence. His studies contribute to clinical practice, healthcare policy development, and pharmaceutical governance. The broad thematic coverage of his work illustrates a capacity to address both specialized and system-level healthcare challenges.[1]
Award Suitability
The Innovative Research Award recognizes individuals who demonstrate originality, sustained scholarly productivity, and meaningful research outcomes. Ferrara’s record of publications, international collaborations, and healthcare-focused investigations aligns with these criteria. His contributions support innovation in pharmacological science and evidence-based healthcare management.[4]
Conclusion
Francesco Ferrara has established a notable academic profile through sustained research activity, clinical expertise, and interdisciplinary collaboration. His contributions to pharmacology and healthcare policy provide practical and scholarly value. These achievements support his recognition as a strong candidate for the Innovative Research Award.[5]
External Links
References
- ORCID. (2026). Francesco Ferrara (ORCID iD: 0000-0001-9298-6783). ORCID Registry.
https://orcid.org/0000-0001-9298-6783 - Ferrara, F., De Berardinis, F., Scognamiglio, M., & Zovi, A. (2026). The shifting paradigm of monoclonal antibodies in COVID-19 management: From early triumphs to viral resistance and future perspectives. Antibodies, 15(3), Article 48.
https://doi.org/10.3390/antib15030048 - Ferrara, F. (2026). Therapeutic update on alopecia areata: A critical review of standard and emerging targeted therapies. Inflammopharmacology.
https://doi.org/10.1007/s10787-026-02273-8 - Ferrara, F., Martellone, L., Vaccaro, M., Coluccia, A., Scognamiglio, M., Langella, R., Zovi, A., & Polito, G. (2025). Real-life impact of cefiderocol in carbapenem-resistant Acinetobacter baumannii infections (CRAb): A narrative review. European Journal of Clinical Pharmacology.
https://doi.org/10.1007/s00228-025-03866-y - Elsevier. (2026). Scopus Author Profile: Francesco Ferrara (Author ID: 59464334600). Scopus Preview.
https://www.scopus.com/authid/detail.uri?authorId=59464334600